Gilead Sciences | GILD - Stock

Stock Price
140.41
Daily Change
1.04 0.75%
Monthly
-6.41%
Yearly
25.49%
Q2 Forecast
130.22

Gilead Sciences reported $1.78B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
ALKERMES USD 196.62M 5.63M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
J&J USD 14.19B 45M Dec/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025